Uzm. Dr. Sinemis Çelik

• Carcinoma, Transitional Cell 3 publications
  Source: OpenAlex / PubMed MeSHView publications
• Urologic Neoplasms 2 publications

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medicalpark.com.tr.

Experience

• Experience2005 – 2011 Pamukkale Üniversitesi Tıp Fakültesi İç Hastalıkları Ana Bilim Dalı Öğretim Görevlisimedicalpark.com.tr
• Experience2011 Hakkari Devlet Hastanesi İç Hastalıkları Devlet Hizmet Yükümlülüğü Uzman Dr. 3 Ay Sürelimedicalpark.com.tr
• Experience2011 – 2014 Dr. Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi Tıbbı Onkoloji Kliniği Tıbbi Onkoloji Yan Dal Asistanlığımedicalpark.com.tr
• Experience2014 – 2017 Edirne Sultan I.Murat Devlet Hastanesi Tıbbi Onkoloji Uzmanımedicalpark.com.tr
• Experience2017 Okan Üniversitesi Hastenesi, Tıbbi Onkoloji Dr. Öğretim Üyesi Eğitim Komitesi Başkanımedicalpark.com.tr
• Experienceİstanbul Onkoloji Hastanesimedicalpark.com.tr
• ExperienceMedical Park İstanbul Onkoloji Hastanesimedicalpark.com.tr

Education

• EducationPamukkale Üniversitesi Tıp Fakültesimedicalpark.com.tr
• EducationYönetilen Yüksek Lisans Tezimedicalpark.com.tr
• EducationNon-Hodgkin Lenfoma Olgularımızın Klinik, Patolojik, Prognostik Özelliklerinin ve Tedavi Sonuçlarının Değerlendirilmesi.medicalpark.com.tr

• SpecialtyMedical Oncologymedicalpark.com.trFrom source
• Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
• InstitutionMedical Park İstanbul Onkoloji Hastanesimedicalpark.com.trFrom source
• Area of workCarcinoma, Transitional CellExtracted from 3 publications · Model version —From source
• Publications16 publicationsOpenAlex, ORCIDFrom source
• ORCID0000-0002-5712-0711ORCIDFrom source
• Last synchronised4 November 2026 20:55https://www.medicalpark.com.tr/hekimler/sinemis-celikmedicalpark.com.tr

1. Real-world practices in RAS wild-type metastatic colorectal cancer patients treated with targeted agents in the first-line a nationwide onco-colon Turkey registry

   Anadolu Kliniği Tıp Bilimleri Dergisi, 2026

   DOI 10.21673/anadoluklin.1675424 Open-access full textSource: OpenAlex

2. Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma

   Immunotherapy, 2026

   DOI 10.1080/1750743x.2026.2722548 PMID 42683510 Open-access full textSource: OpenAlex

3. Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study

   Clinics and Practice, 2026

   DOI 10.3390/clinpract16090158 PMID 42783081 Open-access full textSource: OpenAlex

4. Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

   Journal of Clinical Medicine, 2026

   DOI 10.3390/jcm15020467 PMID 41598406 Open-access full textSource: ORCID

5. Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

   Clinical Genitourinary Cancer, 2026

   DOI 10.1016/j.clgc.2026.102594 PMID 42349378 Source: OpenAlex

6. Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program

   Future Oncology, 2025

   DOI 10.1080/14796694.2025.2570637 PMID 41103123 Open-access full textSource: OpenAlex

7. KRAS Mutasyonu Saptanmayan Metastatik Kolorektal Kanserli Hastalarda Anti-EGFR Kullanımı-Ulusal Onco-Colon Çalışması Gerçek Yaşam Verleri

   DergiPark (Istanbul University), 2025

   Source: OpenAlex

8. Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program (EAP).

   Journal of Clinical Oncology, 2025

   DOI 10.1200/jco.2025.43.5_suppl.708 1 citation (OpenAlex) Source: OpenAlex

9. Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

   Journal of Oncology Pharmacy Practice, 2024

   DOI 10.1177/10781552241241004 PMID 38613329 Open-access full textSource: OpenAlex

10. Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study.

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.2024.42.16_suppl.e20512 Open-access full textSource: OpenAlex